IL37 and primary biliary cholangitis: Interestingly, in a transgenic murine model of PBC (dominant-negative form of transforming growth factor beta receptor type II) deletion of the p40 subunit, but not the p35 subunit resulted in amelioration of disease severity (32, 33), suggesting an important role for IL-23, but not IL-12 in this pathology.